文献速递腹部介入CTMR

肝脏影像报告和数据系统与肝细胞癌肝移植

LI-RADS and transplantation for hepatocellular carcinoma.
PubMed 文献 · Abdom Radiol (NY) · 2018-01-01

本文综述肝细胞癌(HCC)患者肝移植的影像学评估。LI-RADS观察类别可转换为器官获取与移植网络分类,影像T分期系统用于分期,综述了移植入选标准及候选者优先顺序,并总结了对比剂、动态CT或MRI最低规格及评估肝外转移的接受模态等影像要求。

要点

  • 放射科医生诊断明确HCC(即LR-5类)对分期和移植资格判定起重要作用。
  • LI-RADS观察类别可转换为器官获取与移植网络分类。
  • 综述总结了移植候选者动态CT或MRI的最低规格及可接受的对比剂。

核心结论

  • 放射科医生通过影像无创诊断明确HCC(LR-5类)参与分期和移植资格判定;LI-RADS类别可转换为器官获取与移植网络分类,影像T分期系统及入选标准用于移植评估。

研究设计与样本

  • 综述,阐述LI-RADS观察类别向器官获取与移植网络分类的转换、影像T分期系统、肝移植入选标准及候选者优先顺序,并总结影像要求。

诊断标准与关键数值

  • 明确HCC对应LI-RADS LR-5类,计入分期并用于判定肝移植资格。
  • LI-RADS观察类别可转换为器官获取与移植网络分类。

临床应用与阅片要点

  • 放射科医生诊断LR-5类明确HCC对分期和移植资格判定起重要作用。
  • 移植候选者影像评估需遵循综述总结的对比剂、动态CT或MRI最低规格及评估肝外转移的可接受模态。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Patients with hepatocellular carcinoma (HCC) may be eligible for liver transplantation. Liver transplant candidates with HCC compete for the same deceased donor organs as those without HCC. These scarce organs must be allocated fairly and justly to those who will benefit most. Unlike most other cancers, HCC is often diagnosed noninvasively by imaging without biopsy confirmation. Therefore, radiologists play an important role in diagnosing definite HCC (i.e., LR-5 category) that counts toward staging and determination of liver transplant eligibility. This review explains the conversion of LI-RADS observation categories to organ procurement and transplantation network classes, illustrates the radiologic T-staging systems, reviews selection criteria for liver transplant eligibility, and discusses prioritization of liver transplant candidates with HCC. In addition, this review summarizes imaging requirements, including contrast agents accepted, minimum specifications for dynamic CT or MRI of the liver, and modalities accepted for assessment of extrahepatic spread or metastatic disease in liver transplant candidates with HCC.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Tang A, Fowler KJ, Chernyak V, et al. LI-RADS and transplantation for hepatocellular carcinoma. Abdom Radiol (NY). 2018. PMID: 28612162. doi:10.1007/s00261-017-1210-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。